PATH

NUPATHE INC COM STK

PATH

Delisted

PATH was delisted on the 21st of February, 2014.

Back to rankings

Healthcare Drug Manufacturers - General

Financial journalist opinion

Zacks Investment Research

UiPath (PATH) Suffers a Larger Drop Than the General Market: Key Insights

UiPath (PATH) closed at $11.12 in the latest trading session, marking a -1.24% move from the prior day.

UiPath (PATH) Suffers a Larger Drop Than the General Market: Key Insights

Zacks Investment Research

PATH vs. BKSY: Which High-Tech Stock Holds More Long-Term Potential?

UiPath and BlackSky Technology showcase contrasting growth stories, from automation gains to satellite-driven intelligence.

PATH vs. BKSY: Which High-Tech Stock Holds More Long-Term Potential?

UiPath Appoints Michael Atalla as Chief Marketing Officer to Drive Leadership in Agentic AI and Orchestration

NEW YORK--(BUSINESS WIRE)--UiPath, a global leader in agentic automation, today announced the appointment of Michael Atalla as its new Chief Marketing Officer. Atalla will oversee all facets of the company's global marketing strategy – including brand, performance, demand generation, and communications – playing a central role in elevating UiPath's leadership in agentic AI and orchestration, delivering high-impact solutions, powered by agentic automation, to transform complex business processes.

UiPath Appoints Michael Atalla as Chief Marketing Officer to Drive Leadership in Agentic AI and Orchestration

Zacks Investment Research

UiPath (PATH) Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, UiPath (PATH) closed at $11.17, marking a +2.57% move from the previous day.

UiPath (PATH) Beats Stock Market Upswing: What Investors Need to Know

3 Robotics Stocks at the Heart of the Robotics Revolution

Investors have been looking at robotics companies for several decades. But artificial intelligence (AI) is taking robotics beyond basic automation by bringing more precision, flexibility, and adaptability into the sector.

3 Robotics Stocks at the Heart of the Robotics Revolution

Zacks Investment Research

UiPath Continues Its Momentum With AI-Powered Automation Growth

PATH powers growth with its AI-driven automation platform, posting rising revenues, strong adoption and a major buyback plan.

UiPath Continues Its Momentum With AI-Powered Automation Growth

Zacks Investment Research

UiPath Stock Falls 11% in 3 Months: Should You Buy the Dip or Wait?

UiPath stock slides 11% in three months, but strong automation demand, key tech partnerships and solid finances keep it in focus.

UiPath Stock Falls 11% in 3 Months: Should You Buy the Dip or Wait?

Zacks Investment Research

Automation Boom Fuels PATH's Performance in Growing RPA Market

UiPath's alliances with tech giants, rising revenues, and strong customer retention fuel its edge in the fast-growing automation market.

Automation Boom Fuels PATH's Performance in Growing RPA Market

Zacks Investment Research

UiPath (PATH) Stock Drops Despite Market Gains: Important Facts to Note

UiPath (PATH) reached $10.73 at the closing of the latest trading day, reflecting a -2.37% change compared to its last close.

UiPath (PATH) Stock Drops Despite Market Gains: Important Facts to Note

The Motley Fool

Near 52-Week Low, Should You Buy UiPath Stock?

UiPath (PATH 4.62%) announced an agentic AI product that could drive revenue growth higher.

Near 52-Week Low, Should You Buy UiPath Stock?

See News Rankings

Charts implemented using Lightweight Charts™